Los Angeles Capital Management LLC Travere Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 15,996 shares of TVTX stock, worth $347,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,996
Previous 27,951
42.77%
Holding current value
$347,913
Previous $391,000
28.9%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TVTX
# of Institutions
203Shares Held
85.2MCall Options Held
776KPut Options Held
912K-
Armistice Capital, LLC New York, NY7.65MShares$166 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$166 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$150 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$102 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$94.4 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.4B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...